In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets ...

With limited access to mental health care, people looking for answers about ADHD are turning to TikTok, where information is frequently misleading or inaccurate ...

Karen Winkfield, MD, PhD, addresses the importance of meeting patients where they are to expand clinical trial participation ...

Net research and development expenses for the device division increased in 2024 to CAD175,000 from CAD44,000 in 2023, a 400% increase. The increase is attributed to development of a new software ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

Interest in clinical trials is high, but barriers like cost and lack of doctor communication hinder participation. Survey shows patient eagerness.

Columbia researchers believe their grants are being cut because of diversity components that were imposed by the federal ...

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences has its own resident expert in the fields of ...

Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative ...

Sarepta Therapeutics Inc.'s stock tumbled 23% on Tuesday after the biotech said a patient who used its gene therapy Elevidys for the rare disease Duchenne muscular dystrophy has died of acute liver ...

Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a clinical trial nearly eight years ago, her symptoms have not gotten any worse.